Comparative effects of nitric oxide dependent and independent vasodilation on impaired hindlimb revascularization in eNOS-/- mice

Can J Physiol Pharmacol. 2019 May;97(5):377-385. doi: 10.1139/cjpp-2018-0716. Epub 2019 Jan 9.

Abstract

Ischemia due to vascular occlusion induces vasodilation as an initial response, followed by arteriogenesis or angiogenesis. Vasodilation through nitric oxide (NO) independent and dependent mechanisms may be sufficient to restore the altered neovascularization in pathological situations where the NO is altered. Using a posterior limb claudication model to evaluate ischemia-induced revascularization in eNOS-/- mice, we compared the effects of sodium nitrite, a NO-dependent vasodilator, and prazocin, an alpha-adrenergic blocker and NO-independent vasodilator, on hindlimb revascularization. We evaluated the blood flow of the hindlimbs, NO and nitrites metabolites, the expression of tissue endothelial cell markers and proangiogenic factors, as well as the gait locomotion. Our results suggest that the use of a peripheral vasodilator can substitute the initial absence of NO as an endogenous vasodilator. However, final resolution of the ischemic process requires a NO-mediated pathway, which through changes in vascular hemodynamics, promotes the generation of angiogenic messengers facilitating the functional recovery of the damaged limb.

Keywords: angiogenesis; angiogenèse; arteriogenesis; artériogenèse; eNOS; ischemia; ischémie; maladie vasculaire périphérique; nitric oxide; oxyde nitrique; peripheral vascular disease; revascularisation; revascularization; vasodilatateur; vasodilator.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Hindlimb / blood supply*
  • Ischemia / metabolism
  • Ischemia / pathology
  • Ischemia / physiopathology
  • Mice
  • Mice, Inbred C57BL
  • Neovascularization, Physiologic*
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type III / deficiency*
  • Signal Transduction
  • Vasodilation*

Substances

  • Nitric Oxide
  • Nitric Oxide Synthase Type III